当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Peter McCann and Margaret-Ann McCann
Background and aim: Psychological therapies and some limited pharmacotherapy forms the mainstay of treatment for substance use disorders. However despite extensive research little progress has been made into developing therapies to aid in the initial detoxification phase, the maintenance of remission and to treat the morbidity associated with many drugs of abuse. The following review explores the use of hyperbaric oxygen therapy as an adjunctive treatment for some of the harmful aspects of exposure to alcohol, cocaine and opioids. Method: We conducted a systematic review of articles searched through PubMed for the use of HBOT for conditions related to alcohol, cocaine and opioid use disorders. Outcome measures included improvement in neurocognitive functioning, improvement in withdrawal symptoms and improved sleep and quality of life. Results: Few studies directly investigated the use of HBOT for complications of substance use in humans however several studies were found that looked at conditions with shared features including traumatic brain injury, vascular dementia and chronic pain. Conclusion: There is a lack of human studies assessing the impact of HBOT on sequelae of substance use however findings from animal studies and use of HBOT in related conditions show that there is potential for this therapy in the management of withdrawal syndromes, neurocognitive deficits and quality of life.